By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Cardax Pharmaceuticals Inc. 

99-193 Aiea Heights Drive
Suite 400
Honolulu  Hawaii  96701  U.S.A.
Phone: 808-457-1400 Fax: 808-237-5901



Company News
Cardax Pharmaceuticals Inc. Awarded U.S. Inflammation Patent 11/18/2015 11:46:39 AM
Cardax Pharmaceuticals Inc. Raises Additional $500,000 In Financing 6/30/2015 8:31:41 AM
Cardax Pharmaceuticals Inc. Initiates Monkey Study To Compare Bioavailability Of Patented Consumer Health Product Candidate CDX-085 To Microalgal Astaxanthin 6/18/2015 10:08:07 AM
CAPSUGEL And Cardax Pharmaceuticals Inc. To Collaborate On Development Of Proprietary Astaxanthin Products 8/19/2014 8:53:53 AM
Cardax Pharmaceuticals Inc. Snags Former Novartis AG (NVS), Bristol-Myers Squibb Company (BMY), And Boehringer Ingelheim Corporation Executives As Directors 6/17/2014 6:24:46 AM
Cardax Pharmaceuticals Inc. Release: Recent Studies Further Demonstrate Astaxanthin’s Potential As A Safe And Effective Anti-Inflammatory 5/19/2014 10:00:54 AM
Bradley Willcox Joins Cardax Pharmaceuticals Inc. Scientific Advisory Board 6/27/2011 1:08:06 PM
Cardax Pharmaceuticals Inc. Nominates Clinical Candidate Heptax for Liver Disease; Heptax Ameliorates Inflammation and Oxidative Stress Related to Liver Disease and Metabolic Syndrome 7/20/2009 9:07:33 AM
Cardax Pharmaceuticals Inc. Appoints Gil Rishton, PhD, Chief Science Officer 5/26/2009 3:37:32 PM
Cardax Pharmaceuticals Inc. Release: Study Finds Astaxanthin Is Potent Inhibitor Of Oxidation In Cell Membrane Model 1/2/2007 6:39:47 PM